Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pharmacists on the front line: new program aims to curb opioid misuse

NCT ID NCT05141266

Disease control Sponsor: Jerry Cochran Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests a program where pharmacists provide weekly phone coaching to adults who may be misusing opioid medications. The goal is to reduce risky opioid use and prevent addiction. 350 participants across 14 pharmacies are taking part in this randomized trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Patient Navigation (behavioral intervention)
What this could lead to
If successful, this could provide a practical, community-based program to help people use opioids more safely and reduce the risk of addiction.
What could go wrong
This is a behavioral intervention, not a drug, so effects may be modest. The trial is not yet complete, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 350 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2021

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult (≥18 years) * English speaking * Not receiving cancer treatment * Who have a positive opioid misuse screen on the POMI will be eligible to learn about this study Exclusion Criteria: * Are pregnant (given potential pre/post-natal opioid use complications among pregnant women/offspring * Can-not provide collateral contact information for ≥2 contact persons (to ensure consistent contact/follow up) * Do not have a reliable land line or mobile phone to be contacted by study staff * Are filling only buprenorphine (given some formulations are not indicated for pain) * Plan to leave the area for an extended period of time in the next 6 months * Have had a psychotic and/or manic episode in the last 30 days (before consent, patients will be asked to screen for psychosis * Do not provide permission to access their state prescription drug monitoring data.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid misuse are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

opiate dependence opioid abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Opioid misuse Opioid-related disorders Pharmacist-patient relations

Contacts and locations

Locations

  • University of Utah

    Salt Lake City, Utah, 84108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.